A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
about
The use of herbal medicine in Alzheimer's disease-a systematic reviewBehavioral Abnormality Induced by Enhanced Hypothalamo-Pituitary-Adrenocortical Axis Activity under Dietary Zinc Deficiency and Its Usefulness as a ModelYokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditionsHypnotics and the Occurrence of Bone Fractures in Hospitalized Dementia Patients: A Matched Case-Control Study Using a National Inpatient DatabaseDaily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in miceYi-gan san restores behavioral alterations and a decrease of brain glutathione level in a mouse model of schizophreniaTraditional chinese medicine for chronic fatigue syndrome.Yokukansan and its ingredients as possible treatment options for schizophrenia.Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study.Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat.Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementiaTraditional Japanese Kampo Medicine: Clinical Research between Modernity and Traditional Medicine-The State of Research and Methodological Suggestions for the FutureAn antioxidant phytotherapy to rescue neuronal oxidative stress.Specific binding and characteristics of 18β-glycyrrhetinic acid in rat brain.Inhibitory activities of selected Kampo formulations on human aldose reductaseAmeliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice.Yokukansan, a kampo medicine, protects PC12 cells from glutamate-induced death by augmenting gene expression of cystine/glutamate antiporter system Xc-.Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial.Antiallodynic effect of herbal medicine yokukansan on peripheral neuropathy in rats with chronic constriction injury.Effect of toki-shakuyaku-san on regional cerebral blood flow in patients with mild cognitive impairment and Alzheimer's disease.New possibility of traditional Chinese and Japanese medicine as treatment for behavioral and psychiatric symptoms in dementiaTraditional Chinese medicine: a promising candidate for the treatment of Alzheimer's diseaseYokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.A valid approach in refractory glossodynia: a single-institution 5-year experience treating with Japanese traditional herbal (kampo) medicineEfficacy of Japanese traditional (Kampo) medicine for treating chemotherapy-induced peripheral neuropathy: A retrospective case series study.Compound danshen tablet ameliorated aβ25-35-induced spatial memory impairment in mice via rescuing imbalance between cytokines and neurotrophins.Treatment of posttraumatic stress disorder using the traditional Japanese herbal medicine saikokeishikankyoto: a randomized, observer-blinded, controlled trial in survivors of the great East Japan earthquake and tsunamiSerotonin Receptor Binding Characteristics of Geissoschizine Methyl Ether, an Indole Alkaloid in Uncaria Hook.Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.Herbal therapy: a new pathway for the treatment of Alzheimer's diseaseYokukansan and Yokukansankachimpihange Ameliorate Aggressive Behaviors in Rats with Cholinergic Degeneration in the Nucleus Basalis of Meynert.Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion.Potential usefulness of the kampo medicine yokukansan, containing uncaria hook, for paediatric emotional and behavioural disorders: a case seriesLiquorice-induced hypokalaemia in patients treated with Yokukansan preparations: identification of the risk factors in a retrospective cohort study.Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells.Influences of yokukansankachimpihange on aggressive behavior of zinc-deficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats.Energetics of Excitatory and Inhibitory Neurotransmission in Aluminum Chloride Model of Alzheimer's Disease: Reversal of Behavioral and Metabolic Deficits by Rasa Sindoor.Using Complementary and Alternative Medicine to Treat Pain and Agitation in Dementia: A Review of Randomized Controlled Trials from Long-Term Care with Potential Use in Critical Care.The Kampo medicine Yokukansan (YKS) enhances nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells.Isorhynchophylline alleviates learning and memory impairments induced by aluminum chloride in mice.
P2860
Q24673334-719775A3-3A45-41E8-83B3-D8FD4BEE1355Q26738739-FF719296-2D63-4063-8A4C-A7C61AAA8DD0Q27022174-600F0312-37A8-4C14-971A-7BC5508FE945Q28548098-F221211D-862A-4DD1-99AB-592BC2AF12BDQ30359204-6F14892F-ED60-4827-B568-CA81D2DB6EC4Q30452926-CC739021-7D80-4987-9421-DB3D170A4458Q30483511-A312D523-1AC9-44BB-9DBE-DB405A3C450DQ34140742-94079E58-0CE0-48F5-98D8-F864C66FE267Q34495483-15243929-3891-4C68-9E74-278B52D20B21Q34524383-68C3A5CB-8E76-4788-AF25-A872D5F998E0Q34989295-229F499F-5355-4E32-8B46-59AF9DDA9DF3Q35043493-88BAC616-702B-4351-9BC7-C192EF9CCADBQ35116479-BE9FE6D0-6C4A-4695-96DB-3E943CF99A3FQ35154276-4A39829A-3322-49BE-BE72-4ACC98A97D15Q35397913-189D74A7-7A9A-4AEE-9153-B4AD480CE51CQ35402761-5522910D-AB42-4D03-A138-65874A09D9C6Q35536534-5FF8F792-4DEC-40B9-87BB-E843694B1606Q35543762-AB10A0DC-35DC-4F8D-B412-EFE48E02A81BQ35796363-309A159D-9BAD-476B-87BD-E5F438FBD8C1Q35796586-0D106F44-1891-4646-B063-EA3095ACED98Q36307873-180C33B2-79A6-433B-8DAA-A061B02F4E2CQ36689057-2121770A-9B01-4AAD-BFDD-E4E44E9FD1B6Q36710267-5C165B74-29B8-4F39-B27B-150D61E50EDCQ37275236-05649066-6AF7-4200-B468-A4249BFB4E49Q37345334-BB4A82F2-3817-4C31-9761-96DA6D9EA850Q37502879-DFD50D3C-F16F-4247-95AF-B67117965F2BQ37695924-41AD55E8-E032-4235-810F-7E10CD6330AFQ38891602-FE51EB6E-6527-4CAD-B077-D8F932058F00Q39220519-0B0D528C-6811-4E31-B2A8-1F3983F080A3Q39818663-002AF75E-2638-4FC7-9620-E628B627C4F8Q41790670-462E80FD-7337-42D1-AB00-4976E5F8D0F6Q42112352-E3A51EA4-5D58-41B3-B18B-A8645CC314C2Q42167149-85D5D0F4-C975-4CBE-9374-3BB8E9E516E7Q42267822-8DB93382-472D-4D89-BE36-F6D833970A43Q42363344-4551E104-9D87-4039-A839-97D256264B44Q42367703-88795372-AF08-44CB-A0E7-18CA5C1927EBQ47167624-7699457B-A2DB-40C4-B1F6-2256D6BB45E2Q50138350-60C6EF64-8C31-42BD-96A9-42AEA4FC58E6Q53053726-55504856-1386-4BC7-9ED0-5C2F8B271E41Q55446416-DBD06E6C-92EE-499E-9F13-99E218D4D173
P2860
A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A randomized, observer-blind, ...... y living in dementia patients.
@ast
A randomized, observer-blind, ...... y living in dementia patients.
@en
A randomized, observer-blind, ...... y living in dementia patients.
@nl
type
label
A randomized, observer-blind, ...... y living in dementia patients.
@ast
A randomized, observer-blind, ...... y living in dementia patients.
@en
A randomized, observer-blind, ...... y living in dementia patients.
@nl
prefLabel
A randomized, observer-blind, ...... y living in dementia patients.
@ast
A randomized, observer-blind, ...... y living in dementia patients.
@en
A randomized, observer-blind, ...... y living in dementia patients.
@nl
P2093
P356
P1476
A randomized, observer-blind, ...... ly living in dementia patients
@en
P2093
Haruko Tanji
Hidetada Sasaki
Hironori Fujiwara
Hiroyuki Arai
Koh Iwasaki
Masahiko Fujii
Masahiro Maruyama
Miyako Nemoto
Naoki Tomita
Takashi Seki
P304
P356
10.4088/JCP.V66N0214
P577
2005-02-01T00:00:00Z